Becton, Dickinson and Co. reported $2.9 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q4 Sep/2025 4.10 3.96 Nov/05
FY2026Q3 Jun/2026 3.13 3.68 Aug/06
FY2026Q2 Mar/2026 2.90 2.78 3.35 May/07
FY2026Q1 Dec/2025 2.91 2.81 3.43 Feb/09
FY2025Q4 Sep/2025 3.96 3.92 3.81 Nov/06




Eps Change Date
Abbott USD 1.31 0.16 Jun/2026
Agilent USD 1.43 0.11 Mar/2026
Align Technology USD 2.58 0.71 Mar/2026
AngioDynamics USD -0.07 0.13 Sep/2025
Avanos Medical USD 0.11 0.18 Mar/2026
Baxter International USD 0.36 0.08 Mar/2026
Becton, Dickinson and Co. USD 2.9 0.01 Mar/2026
Bio-Rad Laboratories USD 1.89 0.62 Mar/2026
Boston Scientific USD 0.8 0 Mar/2026
Cooper Companies USD 1.04 0.38 Mar/2026
Danaher USD 1.94 0.12 Jun/2026
Dentsply International USD 0.27 0.2 Mar/2026
Dexcom USD 0.56 0.12 Mar/2026
Edwards Lifesciences USD 0.78 0 Jun/2026
Globus Medical USD 1.12 0.16 Mar/2026
Insulet USD 1.42 0.02 Mar/2026
Integra LifeSciences USD 0.54 0.29 Mar/2026
Intuitive Surgical USD 2.8 0.3 Jun/2026
J&J USD 2.9 0.2 Jun/2026
Medtronic USD 1.55 0.19 Mar/2026
Solventum Corp USD 1.48 0.2 Mar/2026
Stryker USD 2.6 1.87 Mar/2026
Tandem Diabetes Care USD -0.3 0.29 Mar/2026
Teleflex USD 1.39 0.54 Mar/2026
Terumo JPY 17.87 4.27 Mar/2026
Thermo Fisher Scientific USD 6.03 0.59 Jun/2026
Zimmer Biomet Holdings USD 2.09 0.33 Mar/2026